Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Toxocara Canis Large Ribosomal Subunit Protein uL3 (RPL3)

Cat. No.VG2C53

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Toxocara Canis Large Ribosomal Subunit Protein uL3 (RPL3) is a recombinant protein expressed from Yeast. Its predicted molecular weight is 46.0 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Parasite
Expression System Yeast
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 46.0 kDa
Physical State Lyophilized
Formulation Tris/PBS-based buffer, 5%-50% glycerol

Target Information

The Toxocara Canis Large Ribosomal Subunit Protein uL3 is a component of the ribosome, playing a key role in protein synthesis within the parasite. This protein is highly conserved and essential for the stability and function of the ribosome. In veterinary medicine, uL3 is being studied for its potential as a diagnostic marker and vaccine target due to its immunogenic properties. Its presence in the excretory-secretory products of T. canis larvae suggests it may also be involved in immune evasion and host-parasite interactions. Further research is needed to fully explore its applications in controlling toxocariasis.

Protein Toxocara Canis Large Ribosomal Subunit Protein uL3 (RPL3)
Protein Synonym RPL3; 60S ribosomal protein L3
UniProt ID P49149

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket